Skip to main content
Clinical Trials/NCT00266968
NCT00266968
Completed
Not Applicable

Assessment of the Outcomes of Children With Congenital Single Ventricle Heart

Children's Healthcare of Atlanta1 site in 1 country200 target enrollmentJanuary 2000

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congenital Disorders
Sponsor
Children's Healthcare of Atlanta
Enrollment
200
Locations
1
Primary Endpoint
We propose to do a retrospective chart review of patient data including a review of their invasive and non-invasive studies.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Congenital heart disease affects 1 in 100 newborn babies each year and more than 2,000,000 Americans have a congenital heart defect. One common defect treated at Children's Healthcare of Atlanta at Egleston is single ventricle heart. Due to these overwhelming numbers, the use of diagnostic imaging technology to assess these defects and heart function is an important step in the evolving care of this patient group.

Detailed Description

The definition of single ventricle can mean a ventricle that is hypoplastic, too small, or completely absent. Either the right or left ventricle may be affected. There may also be other cardiac anomalies present. Infants with a single ventricle develop distress after birth when the ductus arteriosus and foramen ovale close. This may happen within hours or days of delivery. The severity of symptoms is determined by the degree of defect. But, single ventricle patients will not survive without treatment. Patients with only one functioning ventricle can usually expect either a heart transplant or a series of palliative surgeries or sometimes both. Their care is very complex requiring a team of dedicated practitioners to manage drug therapy, medical support and surgery. At Children's Healthcare of Atlanta at Egleston, it is standard of care for a patient with a single ventricle heart to undergo many non-invasive imaging studies and sometimes invasive studies such as heart catheterization. Results of the studies provide valuable information used for treatment decisions and evaluation of heart function. We propose to do a retrospective chart review of patient data including a review of their invasive and non-invasive studies.

Registry
clinicaltrials.gov
Start Date
January 2000
End Date
December 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Single Ventrical heart

Exclusion Criteria

  • those patients who do not have single ventrical heart

Outcomes

Primary Outcomes

We propose to do a retrospective chart review of patient data including a review of their invasive and non-invasive studies.

Time Frame: 13 years

We propose to do a retrospective chart review of patient data including a review of their invasive and non-invasive studies.

Study Sites (1)

Loading locations...

Similar Trials